Related Experiment Video

Updated: Oct 3, 2026

Phenotypic and Functional Analysis of Activated Regulatory T Cells Isolated from Chronic Lymphocytic Choriomeningitis Virus-infected Mice
07:17

Phenotypic and Functional Analysis of Activated Regulatory T Cells Isolated from Chronic Lymphocytic Choriomeningitis Virus-infected Mice

Published on: June 22, 2016

Antiviral pathway activation in patients with chronic fatigue syndrome and acute infection

J W Gow1, K Simpson, P O Behan

  • 1Department of Neurology, University of Glasgow, Scotland, United Kingdom.

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|November 8, 2001
PubMed

Insights

Gene expression of antiviral enzymes RNA-regulated protein kinase (PKR) and ribonuclease L (RNase L) was studied in chronic fatigue syndrome (CFS) patients. Pathway activation differed significantly in patients with acute infections, not CFS, suggesting it

Area of Science:

  • Immunology
  • Virology
  • Biochemistry

Background:

  • Chronic Fatigue Syndrome (CFS) is a complex condition with unclear diagnostic markers.
  • Antiviral pathways, including ribonuclease latent (RNase L) and RNA-regulated protein kinase (PKR), play crucial roles in immune responses.
  • Investigating these pathways may offer insights into CFS pathogenesis.

Purpose of the Study:

  • To compare the gene expression of key enzymes in the RNase L and PKR antiviral pathways between patients with CFS, acute gastroenteritis, and healthy controls.
  • To determine if activation of these antiviral pathways could serve as a diagnostic marker for CFS.

Main Methods:

  • Gene expression analysis of RNase L and PKR enzymes.
  • Comparison of expression levels in 22 CFS patients, 10 acute gastroenteritis patients, and 21 healthy volunteers.

Main Results:

  • Pathway activation in patients with acute infections was significantly different compared to CFS patients and healthy volunteers.
  • No evidence of upregulation in the RNase L and PKR pathways was found in CFS patients.
  • The study found no significant difference in antiviral pathway activation between CFS patients and healthy controls.

Conclusions:

  • The activation of RNase L and PKR antiviral pathways does not appear to be a reliable biomarker for diagnosing CFS.
  • Further research is needed to identify specific diagnostic markers for Chronic Fatigue Syndrome.

More Related Videos

In Vitro Assay to Evaluate the Impact of Immunoregulatory Pathways on HIV-specific CD4 T Cell Effector Function09:26

In Vitro Assay to Evaluate the Impact of Immunoregulatory Pathways on HIV-specific CD4 T Cell Effector Function

Published on: October 15, 2013

Related Concept Videos

Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...